Literature DB >> 9076748

Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.

D Bleakman1, B A Ballyk, D D Schoepp, A J Palmer, C P Bath, E F Sharpe, M L Woolley, H R Bufton, R K Kamboj, I Tarnawa, D Lodge.   

Abstract

The activity and selectivity of the glutamate receptor antagonists belonging to the 2,3-benzodiazepine class of compounds have been examined at recombinant human non-NMDA glutamate receptors expressed in HEK293 cells and on native rat NMDA and non-NMDA receptors in vitro. The racemic 2,3-benzodiazepines GYKI52466, LY293606 (GYKI53405) and LY300168 (GYKI53655) inhibited AMPA (10 microM)-mediated responses in recombinant human GluR1 receptors expressed in HEK293 cells with approximate IC50 values of 18 microM, 24 microM and 6 microM, respectively and AMPA (10 microM) responses in recombinant human GluR4 expressing HEK293 cells with approximate IC50 values of 22 microM, 28 microM and 5 microM, respectively. GYKI 52466, LY293606 and LY300168 were non-competitive antagonists of AMPA receptor-mediated responses in acutely isolated rat cerebellar Purkinje neurons with approximate IC50 values of 10 microM, 8 microM and 1.5 microM, respectively. The activity of racemic compounds LY293606 and LY300168 was established to reside in the (-) isomer of each compound. At a concentration of 100 microM, GYKI52466, LY293606 and LY300168 produced < 30% inhibition of kainate-activated currents evoked in HEK293 cells expressing either human homomeric GluR5 or GluR6 receptors or heteromeric GluR6+KA2 kainate receptors. The activity of the 2,3-benzodiazepines at 100 microM was weak at kainate receptors, but was stereoselective. Similar levels of inhibition were observed for kainate-induced currents in dorsal root ganglion neurons. Intact tissue preparations were also used to examine the stereoselective actions of the 2,3-benzodiazepines. In the cortical wedge preparation, the active isomer of LY300168, LY303070, produced a non-competitive antagonism of AMPA-evoked depolarizations with smaller changes in depolarizations induced by kainate and no effect on NMDA-dependent depolarizations. LY303070 was also effective in preventing 30 microM AMPA-induced depolarizations in isolated spinal cord dorsal roots with an approximate IC50 value of 1 microM. Synaptic transmission in the hemisected spinal cord preparation was stereoselectively antagonized by the active isomers of LY300168 and LY293606. In summary, these results indicate that 2,3-benzodiazepines are potent, selective and stereospecific antagonists of the AMPA subtype of the non-NMDA glutamate receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9076748     DOI: 10.1016/s0028-3908(96)00156-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  47 in total

1.  Intermediate zone cells express calcium-permeable AMPA receptors and establish close contact with growing axons.

Authors:  C Métin; J P Denizot; N Ropert
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

2.  DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons.

Authors:  J L Scruggs; S Patel; M Bubser; A Y Deutch
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

3.  AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability.

Authors:  W Vandenberghe; E C Ihle; D K Patneau; W Robberecht; J R Brorson
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

4.  Cochlear kainate receptors.

Authors:  Marcello Peppi; Melissa Landa; William F Sewell
Journal:  J Assoc Res Otolaryngol       Date:  2012-01-10

Review 5.  Medicinal chemistry of competitive kainate receptor antagonists.

Authors:  Ann M Larsen; Lennart Bunch
Journal:  ACS Chem Neurosci       Date:  2010-12-10       Impact factor: 4.418

Review 6.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

7.  A series of structurally novel heterotricyclic alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor-selective antagonists.

Authors:  M B Gill; S Frausto; M Ikoma; M Sasaki; M Oikawa; R Sakai; G T Swanson
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

8.  Mechanism of inhibition of GluA2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives: functional consequences of replacing a 7,8-methylenedioxy with a 7,8-ethylenedioxy moiety.

Authors:  Mohammad S Qneibi; Nicola Micale; Silvana Grasso; Li Niu
Journal:  Biochemistry       Date:  2012-02-13       Impact factor: 3.162

Review 9.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

10.  AMPA receptors mediate acetylcholine release from starburst amacrine cells in the rabbit retina.

Authors:  Sally I Firth; Wei Li; Stephen C Massey; David W Marshak
Journal:  J Comp Neurol       Date:  2003-11-03       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.